View drug registration information details.
Items | Registration information |
ID | 2314 |
No | 2314 |
Brand Name | HEBERBIOVAC HB |
Ingredients | RECOMBINANT DNA HEPATITIS B SURFACE ANTIGEN (HBSAG) 20 MCG/ML |
Dosage Form | SUSPENSION FOR INJECTION |
Primary Packaging | VIAL |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 1, 10, 25 VIALS X 1ML/BOX |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR THE ACTIVE IMMUNIZATION AGAINST INFECTION BY HBV INFECTION AND PREVENTION OF ITS POTENTIAL OUTCOMES SUCH AS ACUTE AND CHRONIC HEPATITIS, CIRRHOSIS OF THE LIVER AND PRIMARY CARCINOMA |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE GRAYISH SUSPENSION, SLIGHTLY OPAQUE, WHICH SEPARATES, AFTER SOME SEDIMENTATION TIME, INTO TWO PHASES: ONE LIQUID AND TRANSPARENT, AND ANOTHER ONE UNDER THE FORM OF GEL, WHICH, WHEN SHAKEN, EASILY RE-SUSPENDS AND WHICH IS FREE OF ODD PARTICLES |
Note | |
License Owner | SOKDY OSOTH IMPORT-EXPORT CO., LTD |
Manufacturer | CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY |
Country | CUBA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 08 I 1451/97 |
FDD Registration Date | 26-AUG-2024 |
Expiry Date | 25-AUG-2027 |
Back to drug list
|